Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 10400982)

Published in Hum Mol Genet on August 01, 1999

Authors

T F Tsai1, Y H Jiang, J Bressler, D Armstrong, A L Beaudet

Author Affiliations

1: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

Articles citing this

Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc Natl Acad Sci U S A (2000) 4.54

SnoRNA Snord116 (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice. PLoS One (2008) 2.27

Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation. PLoS Genet (2007) 1.82

Small evolutionarily conserved RNA, resembling C/D box small nucleolar RNA, is transcribed from PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which Is highly expressed in brain. Am J Hum Genet (2000) 1.80

When ribosomes go bad: diseases of ribosome biogenesis. Mol Biosyst (2010) 1.76

Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet (2002) 1.57

Androgenetic haploid embryonic stem cells produce live transgenic mice. Nature (2012) 1.51

A paternal deletion of MKRN3, MAGEL2 and NDN does not result in Prader-Willi syndrome. Eur J Hum Genet (2008) 1.49

Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis (2010) 1.46

The parental non-equivalence of imprinting control regions during mammalian development and evolution. PLoS Genet (2010) 1.41

Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome. Nat Med (2016) 1.39

Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS One (2010) 1.37

Mechanisms of genomic imprinting. Am J Hum Genet (2000) 1.34

Deficiency of Rbbp1/Arid4a and Rbbp1l1/Arid4b alters epigenetic modifications and suppresses an imprinting defect in the PWS/AS domain. Genes Dev (2006) 1.27

Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Hum Mol Genet (2012) 1.26

Identification of novel imprinted transcripts in the Prader-Willi syndrome and Angelman syndrome deletion region: further evidence for regional imprinting control. Am J Hum Genet (2000) 1.24

Lack of Pwcr1/MBII-85 snoRNA is critical for neonatal lethality in Prader-Willi syndrome mouse models. Mamm Genome (2005) 1.22

Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model. PLoS Genet (2013) 1.18

MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acids Res (2004) 1.17

Transcription is required to establish maternal imprinting at the Prader-Willi syndrome and Angelman syndrome locus. PLoS Genet (2011) 1.14

Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes. Mol Cell Biol (2012) 1.03

Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization. PLoS Genet (2006) 0.95

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders. Brain Res (2014) 0.93

Deficiencies in the region syntenic to human 21q22.3 cause cognitive deficits in mice. Mamm Genome (2010) 0.91

Mouse chromosome engineering for modeling human disease. Annu Rev Genomics Hum Genet (2006) 0.90

Gabrb3 gene deficient mice exhibit increased risk assessment behavior, hypotonia and expansion of the plexus of locus coeruleus dendrites. Brain Res (2006) 0.87

The neurobiology of mouse models syntenic to human chromosome 15q. J Neurodev Disord (2011) 0.85

Snord116 is critical in the regulation of food intake and body weight. Sci Rep (2016) 0.84

A haplolethal locus uncovered by deletions in the mouse T complex. Genetics (2002) 0.83

An unexpected function of the Prader-Willi syndrome imprinting center in maternal imprinting in mice. PLoS One (2012) 0.83

A deficiency in the region homologous to human 17q21.33-q23.2 causes heart defects in mice. Genetics (2006) 0.81

Differential gene expression reveals mitochondrial dysfunction in an imprinting center deletion mouse model of Prader-Willi syndrome. Clin Transl Sci (2013) 0.81

Regulatory elements associated with paternally-expressed genes in the imprinted murine Angelman/Prader-Willi syndrome domain. PLoS One (2013) 0.81

Global deficits in development, function, and gene expression in the endocrine pancreas in a deletion mouse model of Prader-Willi syndrome. Am J Physiol Endocrinol Metab (2011) 0.80

Temporal and developmental requirements for the Prader-Willi imprinting center. Proc Natl Acad Sci U S A (2012) 0.80

Maternal transcription of non-protein coding RNAs from the PWS-critical region rescues growth retardation in mice. Sci Rep (2016) 0.78

Controlled somatic and germline copy number variation in the mouse model. Curr Genomics (2010) 0.76

Novel Tandem Duplication in Exon 1 of the SNURF/SNRPN Gene in a Child with Transient Excessive Eating Behaviour and Weight Gain. Mol Syndromol (2012) 0.75

The neurobiology of the Prader-Willi phenotype of fragile X syndrome. Intractable Rare Dis Res (2016) 0.75

Zebrafish Models of Prader-Willi Syndrome: Fast Track to Pharmacotherapeutics. Diseases (2016) 0.75

Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models. Epigenomics (2016) 0.75

Articles by these authors

Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet (1993) 7.97

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14

Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 6.79

Effect of a general practitioner's consulting style on patients' satisfaction: a controlled study. BMJ (1990) 6.15

Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol (1985) 5.22

Referral to hospital: perceptions of patients, general practitioners and consultants about necessity and suitability of referral. Fam Pract (1987) 5.11

Two mechanisms of quantized calcium release in skeletal muscle. Nature (1996) 4.95

Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron (1998) 4.92

De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet (1997) 4.65

Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60

Comparison of criteria derived by government and patients for evaluating general practitioner services. BMJ (1989) 4.36

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med (1981) 4.31

Uniparental disomy as a mechanism for human genetic disease. Am J Hum Genet (1988) 4.21

Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet (1994) 4.04

Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 4.02

Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis (1985) 4.00

Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med (1995) 3.83

Aspergillosis complicating neoplastic disease. Am J Med (1973) 3.80

Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet (1989) 3.74

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ (1999) 3.62

Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1993) 3.57

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ (2000) 3.45

Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet (1997) 3.32

Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis (1972) 3.28

Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med (1994) 3.25

Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med (1985) 3.19

Reasons for referral to hospital: extent of agreement between the perceptions of patients, general practitioners and consultants. Fam Pract (1986) 3.14

Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol (1983) 3.09

The American Society of Human Genetics statement on cystic fibrosis screening. Am J Hum Genet (1990) 3.07

Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother (1997) 3.06

Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J Exp Med (1996) 3.04

A reevaluation of cancer incidence near the Three Mile Island nuclear plant: the collision of evidence and assumptions. Environ Health Perspect (1997) 3.04

Investigation of burnout in a sample of British general practitioners. Br J Gen Pract (1995) 3.03

Intraorbital wood. Detection by magnetic resonance imaging. Ophthalmology (1990) 2.99

Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med (1977) 2.92

Measuring general practitioner referrals: patient, workload and list size effects. J R Coll Gen Pract (1988) 2.91

Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci (1997) 2.87

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther (2003) 2.83

Spontaneous skin ulceration and defective T cell function in CD18 null mice. J Exp Med (1998) 2.81

Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med (1984) 2.80

Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol (1999) 2.73

LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J Clin Invest (1997) 2.71

8-Azaguanine resistance in mammalian cells. I. Hypoxanthine-guanine phosphoribosyltransferase. Genetics (1972) 2.71

Species identification of coagulase-negative staphylococcal isolates from blood cultures. J Clin Microbiol (1982) 2.71

Preferences of healthy and ill patients for style of general practitioner care: implications for workload and financial incentives under the new contract. Br J Gen Pract (1991) 2.66

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet (1998) 2.65

Telephone consultations in general practice: an additional or alternative service? Br J Gen Pract (1995) 2.62

Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol (1971) 2.60

Septicemia due to Aeromonas hydrophila: clinical and immunologic aspects. J Infect Dis (1973) 2.55

Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science (1996) 2.55

Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. J Biol Chem (1975) 2.55

Oxidative damage to DNA in diabetes mellitus. Lancet (1996) 2.54

Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis (1990) 2.51

Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract (2001) 2.50

Patients' views of priority setting in health care: an interview survey in one practice. BMJ (1995) 2.50

Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization. Proc Natl Acad Sci U S A (1987) 2.48

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc Natl Acad Sci U S A (1999) 2.41

Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis (1990) 2.39

Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer (1974) 2.36

P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med (2000) 2.32

Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol (1993) 2.32

Pneumothorax in AIDS. Ann Intern Med (1991) 2.29

Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J Clin Invest (1998) 2.28

Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum. Science (1979) 2.26

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron (1999) 2.25

Nocardia asteroides infection complicating neoplastic disease. Am J Med (1971) 2.23

Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med (1993) 2.22

Autism as a disorder of neural information processing: directions for research and targets for therapy. Mol Psychiatry (2004) 2.19

The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol (1980) 2.19

Functional conservation of atonal and Math1 in the CNS and PNS. Development (2000) 2.18

Phycomycosis complicating leukemia and lymphoma. Ann Intern Med (1972) 2.17

Increased arabinitol levels in experimental candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection. J Infect Dis (1982) 2.16

Nude mouse: a new experimental model for Pneumocystis carinii infection. Science (1977) 2.16

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.14

Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism. Lancet (1988) 2.13

Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet (2009) 2.13

Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci (1999) 2.12

Clinical spectrum of infection due to Bacillus species. Am J Med (1973) 2.11

Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias. J Bacteriol (1966) 2.10

Comparative recovery of fungi from biphasic and conventional blood culture media. J Clin Microbiol (1981) 2.09

Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice. J Exp Med (1997) 2.08

Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med (1981) 2.07

In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species. Eur J Clin Microbiol Infect Dis (1990) 2.06

Patterns of work in general practice in the Bromley health district. J R Coll Gen Pract (1987) 2.05

A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest (1997) 2.04

PCV-2 genotype definition and nomenclature. Vet Rec (2008) 2.04

Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev (1996) 2.04

P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest (1995) 2.02

Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev (2001) 1.99

Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 1.99

The patient's view. Soc Sci Med (1984) 1.97

Detection of HIV-1 DNA sequences in pre-ejaculatory fluid. Lancet (1992) 1.93

Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J (1996) 1.93

Cryptosporidium and cryptosporidiosis. Rev Infect Dis (1987) 1.91

The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol (2000) 1.91